Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jiepeng Tong"'
Autor:
Xiaomin Shen, Jiajie Zhang, Yicheng Huang, Jiepeng Tong, Li Zhang, Zhijuan Zhang, Wei Yu, Yunqing Qiu
Publikováno v:
Journal of Intensive Care, Vol 8, Iss 1, Pp 1-10 (2020)
Abstract Objectives The aim of this study was to systematically assess the accuracy of circulating microRNAs (miRNAs) as a promising biomarker for sepsis via a meta-analysis. Methods PubMed, Cochrane Library, Embase, Web of Science, Scopus, and Ovid
Externí odkaz:
https://doaj.org/article/5986946b4f954e2eb28ffca04111a891
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 927-934 (2020)
Abstract Introduction Enterococcus faecalis is a significant cause of nosocomial infections and is difficult to treat because of intrinsic and acquired resistance to many antibiotics. In addition, the emergence of linezolid-resistant E. faecalis (LZR
Externí odkaz:
https://doaj.org/article/cd64f6af314446a5861338dacfabc6aa
Autor:
Yaqiong Zhan, Lushun Jiang, Xuehang Jin, Shuaibing Ying, Zhe Wu, Li Wang, Wei Yu, Jiepeng Tong, Li Zhang, Yan Lou, Yunqing Qiu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 133, Iss , Pp 110996- (2021)
RRM2, the small subunit of ribonucleotide reductase, is identified as a tumor promotor and therapeutic target. It is common to see the overexpression of RRM2 in chemo-resistant cancer cells and patients. RRM2 mediates the resistance of many chemother
Externí odkaz:
https://doaj.org/article/e948f89f19d045f4a6eb6ae82f490767
Autor:
Zhe Wu, Yaqiong Zhan, Li Wang, Jiepeng Tong, Li Zhang, Mengjia Lin, Xuehang Jin, Lushun Jiang, Yan Lou, Yunqing Qiu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 130, Iss , Pp 110556- (2020)
Backgrounds: Ribonucleotide reductase (RR) catalyzes the essential step in the formation of all four deoxynucleotides. Upregulated activity of RR plays an active role in tumor progression. As the regulatory subunit of RR, ribonucleotide reductase sub
Externí odkaz:
https://doaj.org/article/81cf2bdf8c2741c28023a37e3d4305d8
Autor:
Wei Yu, Li Zhang, Jiepeng Tong, Shuaibing Ying, Xuehang Jin, Hao Xu, Yunqing Qiu, Yiheng Jiang
Publikováno v:
Drug Design, Development and Therapy
Jiepeng Tong,1 Yiheng Jiang,2 Hao Xu,1 Xuehang Jin,1 Li Zhang,1 Shuaibing Ying,1 Wei Yu,1 Yunqing Qiu1 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127941d844e3dd82e4f73c864632cb58
https://doi.org/10.2147/dddt.s315061
https://doi.org/10.2147/dddt.s315061
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 927-934 (2020)
Infectious Diseases and Therapy
Infectious Diseases and Therapy
Introduction Enterococcus faecalis is a significant cause of nosocomial infections and is difficult to treat because of intrinsic and acquired resistance to many antibiotics. In addition, the emergence of linezolid-resistant E. faecalis (LZR-Efa) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::211f78388f656d1f8ffd2b80073ed09f
https://doaj.org/article/cd64f6af314446a5861338dacfabc6aa
https://doaj.org/article/cd64f6af314446a5861338dacfabc6aa
OBJECTIVES Dengue is an endemic viral disease affecting tropical and subtropical regions around the world. The aim of this study was to retrospectively study the clinical characteristics of dengue fever (DF) and evaluate the metabolomic changes. METH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed7bf47bece7934d3e89f2021fbaf5d0
https://doi.org/10.21203/rs.3.rs-617844/v1
https://doi.org/10.21203/rs.3.rs-617844/v1
Aims The purpose of this study was to perform an assessment of circulating microRNAs (miRNAs) as promising biomarker for hepatitis C virus (HCV)-associated hepatocellular carcinoma (HCV-HCC) through a meta-analysis. Methods A comprehensive literature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7efdcb7ca924037aeeb18a406cde6028
https://doi.org/10.21203/rs.3.rs-251826/v1
https://doi.org/10.21203/rs.3.rs-251826/v1
Autor:
Shuaibing Ying, Xuehang Jin, Yan Lou, Lushun Jiang, Zhe Wu, Yaqiong Zhan, Yunqing Qiu, Jiepeng Tong, Li Wang, Wei Yu, Li Zhang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 133, Iss, Pp 110996-(2021)
RRM2, the small subunit of ribonucleotide reductase, is identified as a tumor promotor and therapeutic target. It is common to see the overexpression of RRM2 in chemo-resistant cancer cells and patients. RRM2 mediates the resistance of many chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::748827c3bf635ab04955af70a6c910cd
https://pubmed.ncbi.nlm.nih.gov/33227712
https://pubmed.ncbi.nlm.nih.gov/33227712
Autor:
Xiaomin Shen, Jiajie Zhang, Yicheng Huang, Jiepeng Tong, Zhang, Li, Zhijuan Zhang, Yu, Wei, Yunqing Qiu
Additional file 3: Supplemental Table 1. The research type and severity characteristics of 22 included studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::160f40f71fcf43161e0e13da40fbd319